SCHEMBL618538

SCHEMBL618538

[CH2]C(C)CCC=C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2859080 1.00
SCHEMBL1372187 1.00
SCHEMBL2231883 0.87 KMT2A (0.61)
SCHEMBL2231885 0.87 KMT2A (0.61)
SCHEMBL27920233 0.85 ALOX15 (0.45)
SCHEMBL27920265 0.83 ALOX15 (0.43)
SCHEMBL23581537 0.83 ALOX15 (0.59)
SCHEMBL29120332 0.79
SCHEMBL5855330 0.78 ALOX15 (0.34)
SCHEMBL5855322 0.78 ALOX15 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 437 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233779-B1 NOVEL PROCESS FOR PREPARING SYNTHESIS INTERMEDIATES USING PRODUCTS OF NATURAL ORIGIN AND USE OF THE INTERMEDIATES OBTAINED CENTRE NAT RECH SCIENT (FR) 2023-07-19 EP claimed
EP-2816053-B1 BASE-PROTECTED OLIGONUCLEOTIDE AJINOMOTO KK (JP) 2021-03-24 EP claimed
US-20170327449-A1 NOVEL PROCESS FOR PREPARING SYNTHESIS INTERMEDIATES USING PRODUCTS OF NATURAL ORIGIN AND USE OF THE INTERMEDIATES OBTAINED CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2017-11-16 US claimed
US-20170226070-A1 METHODS AND COMPOSITIONS FOR GAMMA-GLUTAMYL CYCLE MODULATION CANCER RESEARCH TECHNOLOGIES LLC 2017-08-10 US claimed
WO-2017100514-A1 LIPOPHILIC ANALOGS OF CJ-16264, METHODS OF USE, AND SYNTHESIS THEREOF WILLIAM MARSH RICE UNIVERSITY (US) 2017-06-15 WO claimed
EP-2822682-B1 MICROCAPSULES AND USES THEREOF FIRMENICH & CIE (CH) 2017-04-26 EP claimed
US-9371353-B2 Oligonucleotide with protected base AJINOMOTO CO., INC. (JP) 2016-06-21 US claimed
EP-2968346-A2 METHODS AND COMPOSITIONS FOR GAMMA-GLUTAMYL CYCLE MODULATION Cancer Research Technology LLC (US) 2016-01-20 EP claimed
CN-105246483-A Methods and compositions for gamma-glutamyl cycle modulation CANCER RES TECHNOLOGY LLC 2016-01-13 CN claimed
EP-2757905-B1 ACETALS AND KETALS AS FRAGRANCES AND FLAVORS SYMRISE AG (DE) 2015-08-19 EP claimed
US-4837342-A STABILITY SAGAMI CHEMICAL RESEARCH CENTER (JP) 1989-06-06 US claimed
EP-0260655-A2 Unsaturated fatty acid derivatives and their production SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1988-03-23 EP claimed
US-4699921-A CIRCULATION AMELIORATING AND ANTIULCER EFFECT MITSUBISHI YUKA PHARMACEUTICAL CO., LTD. (JP) 1987-10-13 US claimed
EP-0234576-A1 Prostacyclin analogue, and blood circulation improving agent and anti-ulcer composition containing it as active ingredient SAGAMI CHEMICAL RESEARCH CENTER (JP) 1987-09-02 EP claimed
EP-0171992-A2 Pharmaceuticals containing prostaglandin I2 MITSUBISHI KASEI CORPORATION (JP) 1986-02-19 EP claimed
US-4496745-A Epoxycarbacyclin derivatives, their preparation and use SANKYO COMPANY, LIMITED (JP) 1985-01-29 US claimed
US-4423054-A Antihypertensive 4-thiazolidinecarboxylic acids (substituted alkyl derivatives) SANTEN PHARMACEUTICAL CO., LTD. (JP) 1983-12-27 US claimed
US-4347371-A HYPERTENSIVE AGENTS; ANTIDIABETIC AGENTS; VISION DEFECTS SANTEN PHARMACEUTICAL CO., LTD. (JP) 1982-08-31 US claimed
US-4322435-A FOR THROMBOSIS SANKYO COMPANY LIMITED (JP) 1982-03-30 US claimed
EP-0031104-A1 Thiazolidine compounds, processes for their preparation and pharmaceutical compositions containing them SANTEN PHARMACEUTICAL CO., LTD. (JP) 1981-07-01 EP claimed